Deflazacort vs prednisone treatment for Duchenne muscular dystrophy: A meta‐analysis of disease progression rates in recent multicenter clinical trials

INTRODUCTION: In this study we characterized disease progression over 48 weeks among boys receiving deflazacort vs prednisone/prednisolone placebo arm treatment in two recent Duchenne muscular dystrophy (DMD) clinical trials. METHODS: Ambulatory boys with DMD receiving placebo in the phase 3 atalure...

Descripción completa

Detalles Bibliográficos
Autores principales: McDonald, Craig M., Sajeev, Gautam, Yao, Zhiwen, McDonnell, Erin, Elfring, Gary, Souza, Marcio, Peltz, Stuart W., Darras, Basil T., Shieh, Perry B., Cox, David A., Landry, John, Signorovitch, James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Clinical Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6973289/
https://www.ncbi.nlm.nih.gov/pubmed/31599456
http://dx.doi.org/10.1002/mus.26736

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6973289/
https://www.ncbi.nlm.nih.gov/pubmed/31599456
http://dx.doi.org/10.1002/mus.26736

Ejemplares similares